• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PINPNT GELCAP, WO GUIDE; SYSTEM, IMAGING, PULSED ECHO, ULTRASONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PINPNT GELCAP, WO GUIDE; SYSTEM, IMAGING, PULSED ECHO, ULTRASONIC Back to Search Results
Model Number N/A
Device Problem Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/30/2021
Event Type  malfunction  
Manufacturer Narrative
The manufacturer has received the sample and will evaluate.Results are expected soon.A lot history review (lhr) of hufr0255 showed seven other similar product complaint(s) from this lot number.The complaints for this lot number (hufr0255) have been reported from the same facility.
 
Event Description
It was reported "upon opening the package, there is mold in the gel caps.8 units were found similar in nature and they were pulled." no other information was provided.This report addresses the eighth device.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, complaint and batch history, applicable previous investigation(s), applicable manufacturing records, sample analysis and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of contamination in the pinpoint gel caps was confirmed and appears to be related to the manufacturing process.The products returned for evaluation were eight pinpoint gel caps.Of the returned samples, three were returned in open packaging while five were returned unopened.All of the gel caps were from the same lot, hufr0255.Gross visual observation of the samples revealed contamination on all of the gel caps, with the contamination on the sealed gel caps visible through the device packaging.The contaminant appeared to be small spots that appeared dark under gross visual examination but appeared a brownish/beige under microscopic examination.Dimensions were taken on a subset of the spots on some of the samples.The spots ranged in size from 0.00350¿ to 0.11623¿.Dark specks were seen within most of the spots.The area inside the spots was lighter than the external edges of most of the spots.Some of the spots contained a mottled appearance and/or an iridescent sheen.The front side of the gel pads appeared free of contaminants.To verify this, the gel pads on a subset of samples were cut longitudinally and a visual inspection of the cross section of the gel revealed that the contaminant was on the back side of the gel but was not present on the front side or embedded within the gel.Two of the sealed packages were functionally tested by fully submerging the packaging in a beaker of blue dyed water.No bubbles were seen emanating from the packaging into the beaker during submersion.After the samples had been submerged, they were opened and examined for blue dye infiltration through the seals or lidstock.No blue dye was seen within the packaging, indicating that there were no breaches in the packaging seal or in the lidstock material.The product sterilization certificate was reviewed which showed that the minimum and maximum dose of gamma sterilization were within the specified range.Samples from similar complaint files were forwarded to the bd materials science & engineering center of excellence for further chemical analysis to try to identify the contaminant.The samples were analyzed using optical microscopy and scanning electron microscopy (sem) with energy dispersive spectroscopy (eds).Eds detected that the spots were composed of copper in addition to the elements that are part of the pinpoint gel material.As the returned samples all showed copper contamination, they will be confirmed.Most of the returned samples were returned sealed and there was no damage to the seals or lidstocks.Therefore, it appeared that the contaminants entered the kits prior to sealing the packaging.The contamination was likely related to the manufacturing process and equipment.The end-item manufacturing facility has been notified of this complaint.Bd is working closely with manufacturing to prevent recurrence of the reported event.
 
Event Description
It was reported "upon opening the package, there is mold in the gel caps.8 units were found similar in nature and they were pulled." no other information was provided.This report addresses the eighth device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PINPNT GELCAP, WO GUIDE
Type of Device
SYSTEM, IMAGING, PULSED ECHO, ULTRASONIC
MDR Report Key12371304
MDR Text Key268265754
Report Number3006260740-2021-03532
Device Sequence Number1
Product Code IYO
UDI-Device Identifier00801741091209
UDI-Public(01)00801741091209
Combination Product (y/n)N
PMA/PMN Number
K120882
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 10/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number9A10000
Device Lot NumberHUFR0255
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2021
Date Manufacturer Received09/30/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-